ANCO’s ASCO Highlights 2019
2019 ANCO's ASCO Highlights in Metastatic Prostate Cancer: New Data on Enzalutamide in mHSPC, Apalutamide+ADT in mCSPC, and Concurrent 2 Hormonal Agents in mCRPC
By
ANCO’s ASCO Highlights 2019
FEATURING
Sumit Shah
By
ANCO’s ASCO Highlights 2019
FEATURING
Sumit Shah
Comments 0
Login to view comments.
Click here to Login
